Zdrowie i gospodarka · 18/03/1998
FDA Releases Draft Guidance on Clinical Trials for Rheumatoid Arthritis Treatments
The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on developing clinical trials for rheumatoid arthritis (RA) treatments, including drugs, devices, and biological products. The agency is now accepting public comments on the document.